Skip to main content

Table 1 Epidemiological and clinical characteristics of the enrolled individuals.

From: Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy

Characteristics

Total sample

HPV-

individuals

HPV+

individuals

HR/HPV+ individuals

Median (IQR) age

37 (28-44)

38 (30-45)

32 (25-39)**

32 (24-38.5)

Age, n (%)

15-24

52 (16.1)

24 (11.6)

28 (24.1)**

28 (25.9)

 

25-34

87 (26.9)

51 (24.6)

36 (31.0)

31 (28.7)

 

35-44

112 (34.7)

76 (36.7)

36 (31.0)

35 (32.4)

 

45-54

72 (21.3)

56 (27.1)

16 (13.8)**

14 (13.0)

Educational level, n (%)

Primary school

5 (1.6)

5 (2.4)

-

-

 

Middle school

73 (22.7)

47 (22.7)

26 (22.6)

23 (21.5)

 

High school

160 (49.7)

95 (45.9)

65 (56.5)

61 (57.0)

 

University

84 (26.1)

60 (29.0)

24 (20.9)

23 (21.5)

Married or divorced, n (%)

187 (58.1)

133 (64.6)

54 (46.6)**

51 (47.2)

Smoking habit, n (%)

Smoker

88 (27.3)

53 (25.7)

35 (30.4)

33 (30.8)

 

Non smoker

160 (49.7)

104 (50.5)

56 (48.7)

52 (48.6)

 

Ex smoker

73 (22.7)

49 (23.8)

24 (20.9)

22 (20.6)

Nulliparity, n (%)

177 (55.0)

102 (49.5)

75 (64.7)**

70 (64.8)

Oral contraceptive use, n (%)

252 (78.5)

155 (75.6)

97 (84.4)

90 (84.1)

Mean (SD) age at first sexual intercourse

18.7 (3.3)

19.1 (3.4)

18.0 (2.9)**

18.0 (2.9)

No of partners since first sexual intercourse, n (%)

0

4 (1.2)

4 (1.9)

-

-

 

1

112 (34.8)

76 (36.9)

36 (31.0)

35 (32.4)

 

2-3

121 (37.6)

81 (39.3)

40 (34.5)

37 (34.3)

 

4-9

62 (19.3)

31 (15.1)

31 (27.7)*

28 (25.9)

 

> 9

23 (7.1)

14 (6.8)

9 (7.8)

8 (7.4)

No of new partners in the last 3 months, n (%)

0

282 (87.6)

189 (91.8)

93 (80.2)**

86 (79.6)

 

1

34 (10.6)

13 (6.3)

21 (18.1)**

20 (18.5)

 

> 1

6 (1.9)

4 (1.9)

2 (1.7)

2 (1.9)

Use of condom, n (%)

Never

89 (27.8)

55 (26.8)

34 (30.1)

33 (31.4)

 

Past

59 (18.4)

37 (18.1)

22 (19.5)

19 (18.1)

 

Current

170 (53.1)

113 (55.1)

57 (50.4)

53 (50.5)

History of Sexually Transmitted Diseases, n (%)

56 (17.7)

25 (12.4)

31 (27.4)**

27 (25.7)

Compliance to PAP test in the last 3 years, n (%)

191 (60.1)

119 (57.8)

72 (64.3)

67 (64.4)

Sample, n (%; 95% CIs)

323

207 (64.1; 57.6-70.6)

116 (35.9; 30.7-41.1)

108 (33.4; 28.3-38.5)

  1. IQR: InterQuartile Range
  2. SD: Standard Deviation
  3. CIs: Confidence Intervals
  4. Comparison vs HPV - individuals: *p < 0.05, **p < 0.01